ARS-1620

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP29125CAS No. ：1698055-85-4Purity：98%

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	1698055-85-4	Cat. No.	BCP29125
Name	ARS-1620
Synonyms	ARS 1620 ;ARS1620;
SMILES	C=CC(=O)N1CCN(CC1)C2=C3C=C(C(=C4C(=O)C=CC=C4F)C(=C3NC=N2)F)Cl.S
Chemical Name
Formula	C21H17ClF2N4O2	M. Wt	430.84
Purity	98%	Storage	Store at 4-8°C
Description	ARS-1620 is a covalent compound with high potency and selectivity for KRAS-G12C.ARS-1620 selectively induces tumor regression in patient-derived tumor models. ARS-1620, an atropisomeric selective KRASG12C inhibitor with desirable PK. KRAS dependency is more profound in vivo compared to 2D-monolayer cell culture. ARS-1620 is a valuable pharmacological tool to interrogate KRAS biology in vivo. ARS-1620 achieves rapid and sustained in vivo target occupancy to induce tumor regression. We use ARS-1620 to dissect oncogenic KRAS dependency and demonstrate that monolayer culture formats significantly underestimate KRAS dependency in vivo. This study provides in vivo evidence that mutant KRAS can be selectively targeted and reveals ARS-1620 as representing a new generation of KRASG12C-specific inhibitors with promising therapeutic potential.